Snapshot · The Peter Attia Drive
Of all ApoB-lowering drug classes (statins, ezetimibe, PCSK9 inhibitors, bile acid sequestrants, CETP inhibitors), only statins can penetrate the blood-brain barrier and affect brain cholesterol synthesis.
Where this was said
At 1:10:31 · chapter starts 1:09:00
Peter pivots to pharmacology, and Tom draws an immediate boundary: only statins among all ApoB-lowering drug classes can penetrate the blood-brain barrier. PCSK9 inhibitors, bile acid sequestrants, ezetimibe, and CETP inhibitors all work outside the brain. In steady state, even hydrophilic statins (like rosuvastatin) ultimately reach the brain, so the lipophilicity distinction matters less than commonly assumed for long-term therapy. Since Alzheimer's pathology involves excessive neuronal cholesterol, the hypothesis that statins might benefit the brain by moderately reducing brain cholesterol synthesis is logically coherent and is supported by the data: meta-analyses of statin trials show statins are either neutral or beneficial with respect to dementia outcomes — no study has shown harm [1] — Tom Dayspring "All statins — hydrophilic or lipophilic — reach the brain in steady state and can reduce cholesterol synthesis there. Meta-analyses show st…" 1:10:00 . But the flip side is real: cholesterol is also essential for brain function, and some patients develop brain fog on statins that promptly resolves on discontinuation. Tom proposes this is the over-suppression subgroup — individuals in whom the statin too aggressively reduces brain cholesterol synthesis. Monitoring plasma desmosterol could identify these patients before symptoms emerge, allowing dose adjustments. Similarly, statins have been shown to reduce plasma 24S-hydroxycholesterol, which Tom interprets as evidence of normalized neuronal cholesterol levels.
All statins — hydrophilic or lipophilic — reach the brain in steady state and can reduce cholesterol synthesis there. Meta-analyses show statins are either neutral or beneficial for dementia risk, but some patients develop brain fog, which may reflect over-suppression. Plasma desmosterol can help calibrate the dose.
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
A study found that simply scheduling enjoyable activities was as effective as standard cognitive behavioral therapy for depression, leading to its own therapy called behavioral activation.
The 'worry time' technique — deferring all worries to a designated time of day — helps people realize they have more control over worry than they thought and reveals it is less useful than it feels.
A study found that participants told to try to stay awake while in bed fell asleep faster than participants told to try to sleep — illustrating the paradox of direct effort.
Spencer Greenberg reduced his severe social anxiety dramatically in roughly 6 months through a structured exposure therapy hierarchy, culminating in asking strangers for hugs.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.